Table 1.
Patient Characteristics (N = 35) | |
---|---|
Median Age, y (range) | 57 (31- 73) |
Stage | |
I | 2 (6%) |
II | 1 (3%) |
III | 24 (69%) |
IV | 8 (23%) |
Histologic Type | |
Serous | 26 (74%) |
Endometrioid | 6 (17%) |
Clear cell | 3 (9%) |
Size of Residual at Primary Debulking | |
Optimal (≤ 1 cm) | 16 (46%) |
Suboptimal (> 1 cm) | 10 (29%) |
Unknown | 9 (26%) |
Primary Chemotherapy | |
Taxane + platinum | 22 (63%) |
Other platinum containing | 13 (37%) |
Second-line Chemotherapy | |
Taxane + platinum | 24 (69%) |
Other platinum combination | 7 (20%) |
Platinum only | 4 (11%) |